| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 1.45e-04 | 435 | 24 | 5 | GO:0004857 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 6.18e-04 | 596 | 24 | 5 | GO:0140678 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase inhibitor activity | 1.21e-03 | 43 | 24 | 2 | GO:0004869 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 1.27e-03 | 180 | 24 | 3 | GO:0004866 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 1.42e-03 | 187 | 24 | 3 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 1.74e-03 | 201 | 24 | 3 | GO:0061135 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 3.49e-03 | 257 | 24 | 3 | GO:0061134 | |
| GeneOntologyMolecularFunction | virus receptor activity | 4.65e-03 | 85 | 24 | 2 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 4.76e-03 | 86 | 24 | 2 | GO:0140272 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | 5.62e-03 | 1418 | 24 | 6 | GO:0030234 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 7.01e-03 | 105 | 24 | 2 | GO:0004867 | |
| GeneOntologyMolecularFunction | GTPase activity | 7.66e-03 | 341 | 24 | 3 | GO:0003924 | |
| GeneOntologyMolecularFunction | GTP binding | 1.16e-02 | 397 | 24 | 3 | GO:0005525 | |
| MousePheno | decreased respiratory mucosa goblet cell number | 1.23e-05 | 5 | 16 | 2 | MP:0010862 | |
| MousePheno | abnormal respiratory mucosa goblet cell morphology | 2.31e-04 | 20 | 16 | 2 | MP:0002281 | |
| Domain | GBP_C | 7.08e-05 | 10 | 24 | 2 | PF02841 | |
| Domain | Guanylate-bd_C | 8.64e-05 | 11 | 24 | 2 | IPR003191 | |
| Domain | GBP | 8.64e-05 | 11 | 24 | 2 | PF02263 | |
| Domain | G_GB1_RHD3_dom | 8.64e-05 | 11 | 24 | 2 | IPR030386 | |
| Domain | Guanylate-bd_N | 8.64e-05 | 11 | 24 | 2 | IPR015894 | |
| Domain | G_GB1_RHD3 | 8.64e-05 | 11 | 24 | 2 | PS51715 | |
| Domain | Serpin_CS | 7.67e-04 | 32 | 24 | 2 | IPR023795 | |
| Domain | Serpin_dom | 9.71e-04 | 36 | 24 | 2 | IPR023796 | |
| Domain | SERPIN | 1.03e-03 | 37 | 24 | 2 | SM00093 | |
| Domain | SERPIN | 1.03e-03 | 37 | 24 | 2 | PS00284 | |
| Domain | Serpin | 1.08e-03 | 38 | 24 | 2 | PF00079 | |
| Domain | Serpin_fam | 1.14e-03 | 39 | 24 | 2 | IPR000215 | |
| Domain | - | 1.42e-02 | 746 | 24 | 4 | 3.40.50.300 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 15203214 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 11267667 | ||
| Pubmed | Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure. | 4.56e-07 | 2 | 24 | 2 | 23354406 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 22406480 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 29491058 | ||
| Pubmed | Serpinb3 is overexpressed in the liver in presence of iron overload. | 4.56e-07 | 2 | 24 | 2 | 28935635 | |
| Pubmed | Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy. | 4.56e-07 | 2 | 24 | 2 | 27668655 | |
| Pubmed | Squamous cell carcinoma antigen production in nasal inverted papilloma. | 4.56e-07 | 2 | 24 | 2 | 23168150 | |
| Pubmed | The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases. | 4.56e-07 | 2 | 24 | 2 | 11863458 | |
| Pubmed | Lysoptosis is an evolutionarily conserved cell death pathway moderated by intracellular serpins. | 4.56e-07 | 2 | 24 | 2 | 35022507 | |
| Pubmed | IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease. | 4.56e-07 | 2 | 24 | 2 | 22808225 | |
| Pubmed | Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice. | 4.56e-07 | 2 | 24 | 2 | 21403642 | |
| Pubmed | Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. | 4.56e-07 | 2 | 24 | 2 | 14970861 | |
| Pubmed | Characterization of novel squamous cell carcinoma antigen-related molecules in mice. | 4.56e-07 | 2 | 24 | 2 | 15504361 | |
| Pubmed | SCCA2-like serpins mediate genetic predisposition to skin tumors. | 4.56e-07 | 2 | 24 | 2 | 12702576 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 10653592 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 29112685 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 10956412 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 20428762 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 25111616 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 35874657 | ||
| Pubmed | Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells. | 1.37e-06 | 3 | 24 | 2 | 19070595 | |
| Pubmed | Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC). | 1.37e-06 | 3 | 24 | 2 | 24635038 | |
| Pubmed | Heparin enhances serpin inhibition of the cysteine protease cathepsin L. | 1.37e-06 | 3 | 24 | 2 | 19959474 | |
| Pubmed | A nonredundant role for mouse Serpinb3a in the induction of mucus production in asthma. | 1.37e-06 | 3 | 24 | 2 | 21126757 | |
| Pubmed | Uteroglobin suppresses SCCA gene expression associated with allergic asthma. | 1.37e-06 | 3 | 24 | 2 | 15677460 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 9828132 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 22451727 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 7724531 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 24898082 | ||
| Pubmed | Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1. | 2.74e-06 | 4 | 24 | 2 | 12949073 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 21576355 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 16549498 | ||
| Pubmed | 4.48e-06 | 162 | 24 | 4 | 23012479 | ||
| Pubmed | 4.56e-06 | 5 | 24 | 2 | 12396730 | ||
| Pubmed | In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. | 1.27e-05 | 8 | 24 | 2 | 16689661 | |
| Pubmed | 2.50e-05 | 11 | 24 | 2 | 15203215 | ||
| Pubmed | Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. | 2.50e-05 | 11 | 24 | 2 | 18025219 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 2.57e-05 | 1353 | 24 | 7 | 29467282 | |
| Pubmed | 3.54e-05 | 13 | 24 | 2 | 11863365 | ||
| Pubmed | Common body mass index-associated variants confer risk of extreme obesity. | 4.77e-05 | 15 | 24 | 2 | 19553259 | |
| Pubmed | 4.77e-05 | 15 | 24 | 2 | 30704515 | ||
| Pubmed | A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection. | 7.75e-05 | 19 | 24 | 2 | 21551061 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 1.03e-04 | 704 | 24 | 5 | 29955894 | |
| Pubmed | A genomic analysis of rat proteases and protease inhibitors. | 1.14e-04 | 23 | 24 | 2 | 15060002 | |
| Pubmed | 1.36e-04 | 25 | 24 | 2 | 35139355 | ||
| Pubmed | Molecular profiling of the vestibular lamina highlights a key role for Hedgehog signalling. | 2.10e-04 | 31 | 24 | 2 | 36971701 | |
| Pubmed | 3.73e-04 | 506 | 24 | 4 | 30890647 | ||
| Pubmed | 4.05e-04 | 43 | 24 | 2 | 24172014 | ||
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 4.11e-04 | 212 | 24 | 3 | 33462405 | |
| Pubmed | 5.59e-04 | 1014 | 24 | 5 | 32416067 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 5.64e-04 | 1016 | 24 | 5 | 19056867 | |
| Interaction | PKD2L2 interactions | 2.43e-07 | 11 | 24 | 3 | int:PKD2L2 | |
| Interaction | ANKK1 interactions | 6.53e-06 | 31 | 24 | 3 | int:ANKK1 | |
| Interaction | FBXO44 interactions | 1.32e-05 | 39 | 24 | 3 | int:FBXO44 | |
| Interaction | FRMD1 interactions | 3.16e-05 | 52 | 24 | 3 | int:FRMD1 | |
| Interaction | STK11 interactions | 3.55e-05 | 326 | 24 | 5 | int:STK11 | |
| Interaction | COL6A6 interactions | 4.87e-05 | 9 | 24 | 2 | int:COL6A6 | |
| Interaction | PKN2 interactions | 6.06e-05 | 183 | 24 | 4 | int:PKN2 | |
| Interaction | FCRL5 interactions | 1.05e-04 | 13 | 24 | 2 | int:FCRL5 | |
| Interaction | GPR18 interactions | 1.23e-04 | 14 | 24 | 2 | int:GPR18 | |
| Interaction | CFAP298 interactions | 1.37e-04 | 85 | 24 | 3 | int:CFAP298 | |
| Interaction | RPS2P32 interactions | 1.41e-04 | 15 | 24 | 2 | int:RPS2P32 | |
| Interaction | FAM227B interactions | 1.61e-04 | 16 | 24 | 2 | int:FAM227B | |
| Interaction | NUDT3 interactions | 2.10e-04 | 98 | 24 | 3 | int:NUDT3 | |
| Interaction | PLAC8L1 interactions | 2.30e-04 | 19 | 24 | 2 | int:PLAC8L1 | |
| Cytoband | 18q21.3 | 1.44e-05 | 11 | 24 | 2 | 18q21.3 | |
| Cytoband | 1p22.2 | 9.82e-05 | 28 | 24 | 2 | 1p22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 2.34e-03 | 137 | 24 | 2 | chr1p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q21 | 5.13e-03 | 205 | 24 | 2 | chr18q21 | |
| GeneFamily | Serpin peptidase inhibitors | 2.22e-04 | 37 | 11 | 2 | 739 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.64e-03 | 206 | 11 | 2 | 682 | |
| ToppCell | Influenza_Severe-B_intermediate|World / Disease group and Cell class | 2.02e-06 | 171 | 24 | 4 | 4d33e1dc1efc423dbdd5f4cca6d6440a68add8d0 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.13e-06 | 191 | 24 | 4 | 29ce21c6e810edd51f13e0fb1083cd44bd57b1d4 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-B_intermediate|Influenza_Severe / Disease, condition lineage and cell class | 3.61e-06 | 198 | 24 | 4 | ab622fee61714471af3a7be0af356e8a484dcaff | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-05 | 160 | 24 | 3 | 55f599df6e3b7a5a505df4b094c834281311d94a | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-05 | 160 | 24 | 3 | 296e53e1e0786346d38db2d4188b9a1c0430627b | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-05 | 164 | 24 | 3 | 1d0d88132baaa3154c3e6e4ef0aff795afab08a2 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-05 | 164 | 24 | 3 | bd2e10b015d5e6a338675500ec5d81dc39583b3e | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.10e-05 | 164 | 24 | 3 | 4ade97931ae1780af7836d988fe117a10b3e88a1 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.77e-05 | 168 | 24 | 3 | 2fb2d916eb5000a637240d38e47a9b4f61f9f83f | |
| ToppCell | ASK440-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.77e-05 | 168 | 24 | 3 | 127559d1a083c68cda9fce143afcc3eec168df17 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.03e-04 | 171 | 24 | 3 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.03e-04 | 171 | 24 | 3 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-04 | 171 | 24 | 3 | a2938e56cb5749004317798dc7ac0f0c2d4d8ae0 | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 1.05e-04 | 172 | 24 | 3 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.07e-04 | 173 | 24 | 3 | 23248019c819f6e38337dcc4edb763ef1992e89e | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.07e-04 | 173 | 24 | 3 | f135cc9dcf34f33ced3210171ab40ae6d77cfae0 | |
| ToppCell | Influenza_Severe-B_intermediate|Influenza_Severe / Disease group and Cell class | 1.08e-04 | 174 | 24 | 3 | 4276bdaac53aebd3084323a90ecde572d3177446 | |
| ToppCell | ASK452-Epithelial-Secretory|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.12e-04 | 176 | 24 | 3 | dd334c8a8a31dc26b2d558df0ef6bed6dc1a6610 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 176 | 24 | 3 | 6b4afd2c9268172063fe5832896bea15e862579e | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.12e-04 | 176 | 24 | 3 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 176 | 24 | 3 | 052b54c4337ca728974a106b6dbd3b72dd28eb23 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.14e-04 | 177 | 24 | 3 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.16e-04 | 178 | 24 | 3 | 499640cfb1063aa40343ec1563e40fe4645466fb | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.16e-04 | 178 | 24 | 3 | 851fdcf1451880a048885cc6677b4edfff6aee4c | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-04 | 178 | 24 | 3 | 1a3b3b73e81ceb26cec8153cd1bdd7b446887a71 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.18e-04 | 179 | 24 | 3 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.20e-04 | 180 | 24 | 3 | 535a890bde0d978b461c2d4c571529b585c76b21 | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.22e-04 | 181 | 24 | 3 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.24e-04 | 182 | 24 | 3 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 1.24e-04 | 182 | 24 | 3 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 182 | 24 | 3 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | Severe_COVID-19-B_cell-B_cell|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.26e-04 | 183 | 24 | 3 | 5634e528001c389efd1e380f01ad40072f60e943 | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 1.26e-04 | 183 | 24 | 3 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.28e-04 | 184 | 24 | 3 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-04 | 185 | 24 | 3 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 1.34e-04 | 187 | 24 | 3 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.34e-04 | 187 | 24 | 3 | 9325cadd5f2c667d526696899e7aa36a98226d4b | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.34e-04 | 187 | 24 | 3 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.34e-04 | 187 | 24 | 3 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.34e-04 | 187 | 24 | 3 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.34e-04 | 187 | 24 | 3 | d2296f2722a24b289fed7e6cfdc2105608437c3e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.34e-04 | 187 | 24 | 3 | 06a0f0a27569af89f86ed8cddb608454a3d40cc5 | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.36e-04 | 188 | 24 | 3 | 13653481d64c7a1ad833d738a3ee0bb9def7cec7 | |
| ToppCell | critical-Epithelial-IRC-IFNG_responsive_cell|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.36e-04 | 188 | 24 | 3 | 023f6e34c2db8657d25e70a97b7b9d45166c13ad | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 1.38e-04 | 189 | 24 | 3 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | CTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 1.38e-04 | 189 | 24 | 3 | 14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 1.41e-04 | 190 | 24 | 3 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-04 | 190 | 24 | 3 | 1f445f24daf4e0e599ee322835b9223ba0e7a1bd | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.41e-04 | 190 | 24 | 3 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-04 | 190 | 24 | 3 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-04 | 190 | 24 | 3 | 682418a7a2096743112eae3790d40e7e600612c0 | |
| ToppCell | COVID_vent-Lymphocytic-B_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.41e-04 | 190 | 24 | 3 | 40b5e9e8f8fd8d84cb5b43e67b49267082348e9f | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-04 | 190 | 24 | 3 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| ToppCell | COVID_vent-Lymphocytic-B_cell-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.41e-04 | 190 | 24 | 3 | a37a32dc1b931562a6660074e19d5598efc65284 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 191 | 24 | 3 | 6cb2c107bc674aa173b4009f320a1687a76f3979 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 191 | 24 | 3 | 529068029fb461df766135576dd0d8b5980f9bc0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.45e-04 | 192 | 24 | 3 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.45e-04 | 192 | 24 | 3 | 24797e80b1f5b3ea5a0410caaf57ccf2ae9d716e | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 192 | 24 | 3 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | 356C-Lymphocytic-B_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 192 | 24 | 3 | f1ac7fa8159f573d140f0e4cbd15256dcb142980 | |
| ToppCell | 356C-Lymphocytic-B_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 192 | 24 | 3 | 1d7a5d15c76ae45551ce104327a2241fbf7d1827 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.45e-04 | 192 | 24 | 3 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.45e-04 | 192 | 24 | 3 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.47e-04 | 193 | 24 | 3 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.47e-04 | 193 | 24 | 3 | 7c34abdcb8839b9fb25457a79af6c5e7b9714b21 | |
| ToppCell | B_cells-Activate_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.47e-04 | 193 | 24 | 3 | b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 193 | 24 | 3 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 193 | 24 | 3 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.49e-04 | 194 | 24 | 3 | b8f05efb16fbed7317019efc3da7f97f81e90972 | |
| ToppCell | PBMC-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-04 | 194 | 24 | 3 | bd2c53fb064edfec76abe56a9ffaced0bda32ab0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 194 | 24 | 3 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-04 | 194 | 24 | 3 | 40251e6415a62fa55d86f2e8609bf0402e1c1abb | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-04 | 194 | 24 | 3 | 54975e663ed4414b99b3c9a1aa6335613946470f | |
| ToppCell | PBMC-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-04 | 194 | 24 | 3 | 7dbedbdece4271e10134c9338c85cb3e04484c75 | |
| ToppCell | control-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.52e-04 | 195 | 24 | 3 | ff7956624b36df34e55295b295a71585accf07bd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 195 | 24 | 3 | 3e24570def013d5b0b1ef1d7a5ced7dfd922590b | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.52e-04 | 195 | 24 | 3 | 955a0a7244cd7eaf006a39e1bd03333baf6f30a4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 195 | 24 | 3 | 24d226f89dd337c22728688e4b40ca082a0e1fe1 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 24 | 3 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 195 | 24 | 3 | 6617abca0009ad3d8731f515f91ab275f9ea4c40 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT2-AT2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.52e-04 | 195 | 24 | 3 | 6867f9c56ea27a17c8c4099aae0d79903c3748a5 | |
| ToppCell | severe-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.52e-04 | 195 | 24 | 3 | 73e39005a597e13aea571ae6ae5824d1c7448b71 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 195 | 24 | 3 | fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 24 | 3 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 195 | 24 | 3 | eec187c087e432417bc346c5d3ead72f58bf3215 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.54e-04 | 196 | 24 | 3 | a7cbe66ebd8931ef2b8ff26a42afce0ad1c48f17 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 196 | 24 | 3 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.54e-04 | 196 | 24 | 3 | 5d5f3c3e9052b7cdca442e39e73b16ca27a16657 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-B-B_intermediate|Bac-SEP / Disease, condition lineage and cell class | 1.54e-04 | 196 | 24 | 3 | 1611920211beb1a3691e3853e0314792a74279a0 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.54e-04 | 196 | 24 | 3 | 03de28e1c963e99623e8b0e33bf2e8ef67dc3baa | |
| ToppCell | distal-3-Epithelial-Proximal_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.54e-04 | 196 | 24 | 3 | 7e1a565dd2da4f375cbce8842ba4fd6c22ac8375 | |
| ToppCell | mild-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.54e-04 | 196 | 24 | 3 | 1988088dd7e1ba947339fd1331beed482955e607 | |
| ToppCell | (5)_Epi_stratified|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.56e-04 | 197 | 24 | 3 | 2b35bcff0637cd5af9bec1ac6bca2b59a92e2f64 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 197 | 24 | 3 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 197 | 24 | 3 | 1d4ccca2ff46fccb3ac052b5148cb7f94231d65a | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD8_T|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.56e-04 | 197 | 24 | 3 | b6ad0a310f557b97d8192a2389692bf3567800cc | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 197 | 24 | 3 | de772bd2b4cda843777ac879b1087e6444199dfb | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.56e-04 | 197 | 24 | 3 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 197 | 24 | 3 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 197 | 24 | 3 | 233b9fcb376e08d0080a05ca0198ecc6ec720f90 | |
| Drug | ChAG | 1.06e-05 | 5 | 24 | 2 | CID000126253 | |
| Drug | dihydroquinoline 31 | 1.06e-05 | 5 | 24 | 2 | CID010561174 | |
| Drug | diaziridine | 1.59e-05 | 6 | 24 | 2 | CID005059686 | |
| Drug | EDKC | 1.59e-05 | 6 | 24 | 2 | CID000129421 | |
| Drug | AC1L1IOA | 2.23e-05 | 7 | 24 | 2 | CID000004663 | |
| Drug | 3'-deoxy-ara-C | 2.97e-05 | 8 | 24 | 2 | CID000122111 | |
| Drug | LS-83913 | 3.82e-05 | 9 | 24 | 2 | CID005488161 | |
| Drug | UNII-75KP30FD8O | 4.77e-05 | 10 | 24 | 2 | CID006450531 | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; PC3; HT_HG-U133A | 5.25e-05 | 199 | 24 | 4 | 2083_DN | |
| Drug | AC1Q5DRM | 1.11e-04 | 15 | 24 | 2 | CID000195100 | |
| Drug | thiirane | 1.43e-04 | 17 | 24 | 2 | CID000009865 | |
| Drug | phenyl hypoiodite | 1.43e-04 | 17 | 24 | 2 | CID000555748 | |
| Disease | response to serotonin-norephinephrine reuptake inhibitor | 3.93e-04 | 36 | 24 | 2 | EFO_0006325 | |
| Disease | BMI-adjusted waist-hip ratio, physical activity measurement | 1.44e-03 | 69 | 24 | 2 | EFO_0007788, EFO_0008002 | |
| Disease | Contact hypersensitivity | 1.52e-03 | 71 | 24 | 2 | C0162351 | |
| Disease | Contact Dermatitis | 1.52e-03 | 71 | 24 | 2 | C0011616 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 2.01e-03 | 312 | 24 | 3 | EFO_0004612, EFO_0010351 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 2.07e-03 | 315 | 24 | 3 | EFO_0004574, EFO_0004612 | |
| Disease | erosive tooth wear measurement | 2.43e-03 | 90 | 24 | 2 | EFO_0009331 | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment | 3.29e-03 | 105 | 24 | 2 | EFO_0007788, EFO_0008007, EFO_0008343 | |
| Disease | Abortion, Tubal | 3.54e-03 | 109 | 24 | 2 | C0000822 | |
| Disease | Early Pregnancy Loss | 3.54e-03 | 109 | 24 | 2 | C3830362 | |
| Disease | Miscarriage | 3.54e-03 | 109 | 24 | 2 | C4552766 | |
| Disease | Spontaneous abortion | 3.54e-03 | 109 | 24 | 2 | C0000786 | |
| Disease | gluteofemoral adipose tissue measurement | 5.14e-03 | 132 | 24 | 2 | EFO_0803317 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IFQKFMESDKFTRFC | 161 | P35626 | |
| VENSVTKEKDMFNFK | 866 | Q5VTR2 | |
| IMKEKENKGFFSFFQ | 231 | Q53SF7 | |
| VEKLEESSFNKKNMF | 661 | Q15283 | |
| KKNKFANTMEFVEDY | 826 | Q14573 | |
| NMFKKFAEQDAKEEA | 411 | Q13451 | |
| EKFKKNMFENFDTFI | 626 | Q5JST6 | |
| FMKNSFKDVDQSFQK | 366 | Q96PP8 | |
| SFKDENQEFQKKFME | 371 | Q6ZN66 | |
| KFKDMNADAVFAFQL | 406 | O43252 | |
| VENKFTFKELTFKMV | 186 | P19086 | |
| FFSVKNPFKEMFTQE | 256 | Q49AR2 | |
| CNKDFFQKMKETAVF | 226 | Q9UBQ7 | |
| KFLQFNSFEFIIMAK | 276 | Q53R41 | |
| EKMAQFDAKKFAETQ | 211 | P26641 | |
| FQASQMKFEDFQKDL | 1566 | Q9NZ56 | |
| KNEKFINAMKEAFET | 536 | Q13620 | |
| FKKMKEFLASVVQDF | 1016 | A6NMZ7 | |
| EVDFKIYKKKMNEFF | 226 | A1Z1Q3 | |
| IYKKKMNEFFSVDDN | 231 | A1Z1Q3 | |
| FSVDFFRKMIQFEKE | 506 | Q9NYH9 | |
| FMFDLFQQFRKSKEN | 11 | P29508 | |
| FMFDLFQQFRKSKEN | 11 | P48594 | |
| IKMEKFVFDIFQFAK | 376 | Q16222 | |
| KSNEVFATFKQEMDK | 376 | Q8N3L3 |